80046010 - Fifth Annual Metastatic Breast Cancer Conference

 Fifth Annual Metastatic Breast Cancer Conference Banner


Date & Location
Thursday, November 15, 2018 - Friday, November 16, 2018, 5:00 PM, Turner Auditorium, Baltimore, MD

Target Audience
Family Practice, General Practice, General Surgery, Internal Medicine, Nurse Practitioner, Nursing, Ob/Gyn, Oncology, Pathology, Physician Assistant, Public Health

Overview
The Metastatic Breast Cancer Conference (MBCC ) was established in 2014 as an annual medical conference for metastatic breast cancer by Theresa’s Research Foundation, with leadership from Dr. Matthew Ellis and Dr. Danny Welch. The specific focus on metastatic disease is based on a major, as yet, unmet clinical need (incurability); thereby distinguishing this conference from other breast cancer-centered conferences. The goal of this meeting is to bring together a diverse audience to create a collaborative research environment to accelerate research with a long term goal of developing curative approaches for metastatic breast cancer patients.

Who Should Attend
This activity is intended for clinicians, patient advocates, scientists, and other healthcare professionals involved in research, treatment, or care of patients with metastatic breast cancer.

Fees
The registration fee includes instructional materials, continental breakfasts, refreshment breaks and lunches.

Johns Hopkins and
Baylor College of Medicine Physicians..............................$125
Physicians....................................................................................................$150
Residents*/Fellows*/Nurses/NPs/PAs/
Allied Health Professionals, PhDs and Post Docs....................................................$100
*with verification of status
Patient Advocates.....................................................................$10

Late Fee And Refund Policy
A $50 late fee applies to registrations received after 5:00 p.m. ET on November 9, 2018. A handling fee of $50 will be deducted for cancellation. An additional fee may apply for cancellation of other events, including workshops and social activities. Refund requests must be received by fax or mail by November 9, 2018. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins activity in lieu of cancellation is not possible.



Objectives
  1. Improve palliative care and end of life counseling for patients with metastatic breast cancer.
  2. Implement evidence-based recommendations for treatment of metastatic breast cancer and its subtypes.
  3. Describe how clinical trials can help improve treatment of metastatic breast cancer.
  4. Discuss how drug resistance pathways can be applied to the treatment of metastatic breast cancer in order to improve outcomes and quality of life.
  5. Discuss how Biomarkers and genomic analysis can be applied to the treatment of metastatic breast cancer in order to improve outcomes and quality of life.

Accreditation
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine, Baylor College of Medicine and Theresa’s Research Foundation. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

National Commission on Certification of Physician Assistants (NCCPA)
PAs may claim a maximum of 15 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.